I think sellers are seeing another delay. I think the significance of the company committing to Dec meeting is they have funding if sales start March Qtr (excluding FDA trial).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025